Assignee
VITAERIS INC
CA·1 granted patent·4 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0171US11827700B2Treatment or prevention of diseases and disorders associated with cells that express IL-6 with Anti-IL-6 antibodiesVITAERIS INC·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 0271US2021332126A1Anti-il-6 antibodies for the treatment of oral mucositisVITAERIS INC·Filed 2021·Application pending·0 cites
- 0362US2024124573A1Use of Anti-Il-6 Antibody, e.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (ABMR)VITAERIS INC·Filed 2023·Application pending·0 cites
- 0445US2023174640A1Use of Anti-IL-6 Antibody, e.g., Clazakizumab for Treatment/Prevention of ARDS Associated with Coronavirus (COVID-19) InfectionVITAERIS INC·Filed 2021·Application pending·0 cites
- 0542US2021070853A1Use of Anti-Il-6 Antibody, e.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (ABMR)VITAERIS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VITAERIS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →